Synthesis of compound 2 (cyclohexanone O-methyl oxime)
To a solution of cyclohexanone (2.0 g, 20.4 mmol) in methanol (20 mL), anhydrous pyridine (2.5 mL, 30.6 mmol) and methoxyammonium chloride (2.3 g, 30.6 mmol) were added. The reaction mixture was allowed to stir under nitrogen for 12 h, and monitored by TLC. After completion, the mixture was diluted with CH 2 Cl 2 (50 mL) and water (50 mL). The organic layer was separated and the aqueous layer was further extracted with CH 2 Cl 2 (2 x 50 mL). The combined organic extracts were washed with 1M HCl (2 x 50 mL) and saturated NaCl (30 mL) and dried with Na 2 SO 4 . Solvent was removed by concentration under reduced pressure. The crude product was purified by column chromatography to yield compound 1 (2.1 g, (81 %)) as colorless oil. 1 H NMR (500 MHz, Chloroform-d) δ 3.82 (s, 3H), 2.45 (t, 2H), 2.21 (m, 2H), 1.68 (t, 2H) , 1.60 (s, 4H). 13 To a solution of 2-adamantanone (3.0 g, 20 mmol) in methanol (20 mL), anhydrous pyridine (2.4 mL, 30 mmol) and methoxyammonium chloride (2.5 g, 30 mmol) were added. The reaction mixture was allowed to stir under nitrogen for 8 h, Electronic Supplementary Material (ESI) for ChemComm. This journal is © The Royal Society of Chemistry 2019 diluted with CH 2 Cl 2 (50 mL) and water (50 mL). The organic layer was separated and the aqueous layer extracted with CH 2 Cl 2 (2 x 50 mL). The combined organic extracts were washed with 1M HCl (50 mL) and saturated NaCl (30 mL) and dried with Na 2 SO 4 . Solvent was removed by concentration under reduced pressure. The crude product was purified by column chromatography to yield compound 2 (2.1 g, 59 %) as colorless oil. 1 Ozone (3-4 %) was produced with an ozone generator, first passed through dried CH 2 Cl 2 (80 mL, -78°C), then bubbled through a solution of Compound 2 (1.0 g, 5.59 mmol) and methyl 4-oxocyclohexane-1-carboxylate (0.58 g, 3.73 mmol) in pentane (120 mL). The reaction was left for 0.5 h. After completion, the solution was flushed with nitrogen for 15 min then concentrated in vacuo. The residue was purified by column chromatography to give compound 3 (0.46 g, 30 %) as colorless oil. 1 To a solution of 3 (0.1 g, 1.8 mmol) in 95 % ethanol (5 mL), 15 % aq. NaOH (2 mL) was added. The mixture was allowed to stir for 3 h and acidified with 3 M HCl (2 mL). Water (10 mL) and EtOAc (10 mL) were added to the solution and the aqueous layer was washed with EtOAc (3 x 10 mL). The combined organic extracts were washed with water (20 mL) and brine (20 mL), dried with Na 2 SO 4 , filtered and concentrated to give compound 3-1 (73 mg, 76%) as white powder. 1 To a solution of oleum (30 % SO 3 , 48 mL, 100 mmol) at 60 ºC, 5-hydoxy-2-adamantanone (2.0 g, 12 mmol) in formic acid (99 %, 12 mL, 0.32 mmol) was added dropwise and stirred vigorously for 0.5 h. Then the solution was allowed to stir for a further 1 h. The residue was then cautiously poured into vigorously stirred methanol (100 mL) at 0 °C. After 2 h at room temperature, the residue was concentrated and poured over ice. The aqueous layer was washed with CH 2 Cl 2 (3 x 30 mL) and the combined organic fractions were washed with brine (2 x 50 mL), dried with Na 2 SO 4 and concentrated in vacuo. The crude product was purified by column chromatography to yield compound 4 (1.3 g, (52 %)) as a white crystalline solid. 1 To a stirring solution of carboxylic acid 5-1 (50 mg, 0.16 mmol) in CH 2 Cl 2 (10 mL), EDC·HCl (50 mg, 0.24 mmol), and DMAP (19 mg, 0.17 mmol) were added. After activating for 1 h, amine alkyne (11 mg, 0.2 mmol) in CH 2 Cl 2 was added to the solution. After 24 h the solvent was removed under reduced pressure, the crude product was purified by column chromatography to yield compound ZJH-2 (44 mg,77%) as white powder. 1 
Parasite culture and synchronization
P. falciparum strain 3D7 was cultured at 37 °C in 5 % O 2 and 5 % CO 2 in N 2 , essentially as previously described by Trager and Jensen [1] with modifications. Briefly, parasites were incubated in petri dishes at 37 °C using 5 % haematocrit of human red blood cells with RPMI Medium1640, supplemented with 25 mM HEPES, 10mg/L Glucose, 0.5 % Albumax II, 0.3 g/L L-Glutamine, 0.015 % Hypoxanthine, 0.125 g/L gentamicin, and 25mM sodium bicarbonate. Synchronization of parasite cultures with 5 % (w/v) D-sorbitol was performed as previously described [2] . To obtain highly synchronized ring-stage parasite cultures, two rounds of 5 % (w/v) Dsorbitol treatment were performed. Parasitaemia and parasite stages were determined by Giemsa-stained thin blood smears.
In vitro Drug Sensitivity Assay
The parasite sensitivity to compound 3, ZJH-1 and ZJH-2 was measured by a fluorescent SYBR Green Ibased 96 microplate assay as described previously with modifications [3, 4] . In brief, highly synchronized ring-stage parasite cultures were diluted with fresh erythrocytes and complete medium to 0.5 % parasitaemia and 2% haematocrit. The cultures were incubated with compound 3, ZJH-1 and ZJH-2at different concentrations according to a 2-fold serially dilution for 72h. Then the cultures were stained with SYBR Green I (Invitrogen) in lysis buffer for 45min at 37 o C in the dark. The fluorescence was measured using Synergy H1 Hybrid Multi-Mode Microplate Reader (BioTek) with excitation and emission wavelength bands centered at 485 and 528 nm, respectively. At least three biological replicates, each in triplicate technical replicates, were carried out. The half-maximal inhibitory concentration (IC 50 ) of compound 3, ZJH-1 and ZJH-2 against P. falciparum 3D7 were calculated and plotting of the sigmoidal dose-response curve was performed using the software GraphPad Prism 5.
In situ labelling of P. falciparum
The mixed stage P. falciparum parasites were prepared in a 6-well plate with 2.5 % haematocrit and 5 % parasitemia in the gassed incubator. 30 µL of diluted probes ZJH-1 and ZJH-2 were dispensed into each well to obtain increasing concentrations (2 μM, 5 μM, 10 μM, 20 μM) and incubated with the cultures for 4 h at 37 o C. An equal volume of 0.1 % DMSO was used as negative control. After incubation, the cultures were harvested and were incubated with 0.1 % saponin for 5 min on ice to lysis the red blood cell. Then the released parasites were pelleted down by centrifugation at 6000 rpm for 4 min and washed three times with ice-cold PI-PBS (protease inhibitors in phosphate buffered saline). Total parasite proteins from each sample were extracted by sonication on ice at 31 % amplification for 2 min (2 s on, 2 s off) [5] and 176 μL clear protein extracts were obtained by centrifugation at 12000 rpm for 5 min.
Fractions were supplemented with 0.20 mM rhodamine-azide (10 mM stock in DMSO; Clickchemistrytools; Rh-N 3 ), 1.0 mM TCEP (52 mM stock in ddH 2 O; SigmaAldrich) and 0.10 mM TBTA ligand (1.667 mM stockin DMSO; Sigma-Aldrich). Samples were gently pipetted and the cycloaddition was initiated by the addition of 1.0 mM CuSO 4 (50 mM stock in ddH 2 O). After incubation at 37 °C for 1 h, 25 μL 5× SDS loading buffer were added and the samples heated for 10 min at 100 °C.
For gel electrophoresis, 20 μL were applied per gel-lane on a SDS-PAGE gel (10% acrylamide). Fluorescence was recorded using a GE Typhoon FLA9500 luminescent image analyser with λ ex/em = 532nm/596nm at 560V.
Preparative in situ label-free ABPP and Quantification
Twelve milliliters of mixed stage P. falciparum parasites were cultured in 100 mm×20 mm petri dishes (Corning) with 2.5%haematocritand 5% parasitemia in the gassed incubator. Probes ZJH-1 and ZJH-2 were dispensed to the cultures and incubated with the parasites for 4 h at 37 o C. The final incubation concentration of ZJH-1 and ZJH-2 are 20 μM and 2 μM, respectively. An equal volume of 0.1 % DMSO was used as negative control. All the experiments using ZJH-1, ZJH-2 and DMSO were run in triplicate. After incubation, the procedures were similar to that in the above in situ labelling of P. falciparum, except in the parasite proteins were extracted in 400 μL PBS and sonicated on ice for 4 min.
Protein concentrations were measured using a BCA assay (Thermo Fisher) and equal protein amounts were pooled and adjusted to a final volume of 376 μL. The lysates were supplemented with 0.20 mMazide-PEG3-biotin conjugate (10 mM stock in DMSO; Sigma-Aldrich), 0.52 mM TCEP (52 mM stock in ddH 2 O) and 0.050 mM TBTA ligand (1.67 mM stock in DMSO). Samples were gently pipetted and the cycloaddition was initiated by the addition of 0.50 mM CuSO 4 (50 mM stock in ddH 2 O). The reaction mixtures were incubated at 37 °C for 1 h. Proteins were precipitated by the addition of a 4-fold volume excess of methanol (3.2 mL)and incubated over night at -20 °C. The samples were centrifuged at 16k rcf for 15 min at 4 °C. The supernatant was discarded and the pellet washed two times with 2 mL of pre-chilled methanol. Subsequently, the pellet was dissolved in 0.5 mL of PBS with 0.4 % SDS by sonication and incubated under gentle mixing with 80 μL of prewashed streptavidin-agarose beads (Thermo Fisher) at room temperature for 3 h. The beads were washed three times with 1 mL of PBS with 0.4 % SDS, twice with 1 mL of 6 M urea and three times with 1 mL of PBS.
The proteins were reduced, alkylated and trypsin digested on the beads. Therefore, 200 μLNH 4 HCO 3 (50 mM) was added to the beads and centrifuged at 8k rcf for 5 min at 4 °C, and repeated once. Then, 100 μL reduction buffer (50 mM NH 4 HCO 3 , 10 mM DTT) was added to the beads, followed by incubation at 37 °C for 3 h. Iodoacetamide was added to a final concentration of 50 mM, followed by reactionin dark at 25 °C for 40 min and then centrifuged at 8k rcf for 5 min at 4 °C. After the beads were washed with 50 mM NH 4 HCO 3 twice, 1 μg trypsin was added to 100 μL 50 mM NH 4 HCO 3 to digestion at 37 °C. The resulting peptides were desalted and concentrated using SepPak C18.The beads were pelleted and the peptide solution loaded to the cartridges. The peptides were dried at 45 °C and stored at -80 °C.
Mass Spectrometry
Prior to LC-MS/MS measurements all peptide samples were reconstituted in 2 % MeCN /0.1 % FA ddH 2 O and centrifuged at 13k rcf for 10 min at 4 °C.
Nanoflow LC-MS/MS analysis was performed with an Easy-nLC1000 system (Thermo Scientific) coupled to an Orbitrap Fusion™ Lumos™ Tribrid™ Mass Spectrometer (Thermo Scientific). Peptides were loaded on a trap column (300 μm i.d.×5mm, packed with Acclaim PepMap RPLC C 18 , 5μm, 100Å), then transferred to an analytical column(75μmi.d.×150mm, packed with Acclaim PepMap RPLC C18, 3 μm, 100 Å) and separated using a gradient from 4% to 10 % B for 5 min, from 10 % 
Data analysis
The raw MS files were analyzed and searched against protein database based on the species of the samples using uniprot-Plasmodium falciparum. The parameters were set as follows: the protein modifications were carbamidomethylation (C) (fixed), oxidation (M) (variable); the enzyme specificity was set to trypsin; the maximum missed cleavages were set to 2; the precursor ion mass tolerance was set to 10 ppm, and MS/MS tolerance was 0.6 Da. Only high confident identified peptides were chosen for downstream protein identification analysis. ZJH-1-P-S Figure S18 . Mass spectrum of the main product of ZJH-1-P-S
